SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cardiome -- CRME -- Ignore unavailable to you. Want to Upgrade?

To: kenhott who wrote (100)11/22/2006 11:14:41 AM
From: dr.praveen  Respond to of 285
 
Not sure if they gave one. I also like the new safety data they put for the IV version.



To: kenhott who wrote (100)11/22/2006 1:50:36 PM
From: former_pgs  Read Replies (1) | Respond to of 285
 
Isn't it a little strange that they're now starting to look at time to recurrence? I couldn't find any data on time to recurrence for the IV formulation, so I wonder if this is an indirect signal from the FDA that TTR is important (understandable).


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News